In a phase 1 trial, CD19/CD20/CD22 CAR T cells produced complete responses in 83% of patients with relapsed/refractory B-cell ...
TCL SunPower Global, a global leader in solar energy solutions, today opened orders across Europe for SunPower Origin, a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results